Synthesis of Amphiphilic pH-Responsive Doxorubicin and Ferrocene-containing Copolyprodrug as Drug Self-delivery System and Its <italic style="font-style: italic">In Vitro</italic> Synergistic Apoptosis and Ferroptosis Tumor Therapy

Xiao-Mei Zhao; Peng Liu

doi:10.1007/s10118-025-3316-8

Your Location：

Home >

Browse articles >

Synthesis of Amphiphilic pH-Responsive Doxorubicin and Ferrocene-containing Copolyprodrug as Drug Self-delivery System and Its In Vitro Synergistic Apoptosis and Ferroptosis Tumor Therapy

RESEARCH ARTICLE | Updated：2025-03-13

- Synthesis of Amphiphilic pH-Responsive Doxorubicin and Ferrocene-containing Copolyprodrug as Drug Self-delivery System and Its In Vitro Synergistic Apoptosis and Ferroptosis Tumor Therapy
- Chinese Journal of Polymer Science Vol. 43, Pages: 1-8(2025)
- Affiliations：
  
  State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China
- Author bio：
  
  pliu@lzu.edu.cn
- Funds：
- DOI：10.1007/s10118-025-3316-8
  CLC：
- Received：27 December 2024，
  
  Revised：22 January 2025，
  
  Accepted：2025-02-06，
  
  Published Online：13 March 2025，
  
  Published：2025-02
- Accepted：
Scan QR Code
Zhao, X. M.; Liu, P. Synthesis of amphiphilic pH-responsive doxorubicin and ferrocene-containing copolyprodrug as drug self-delivery system and its in vitro synergistic apoptosis and ferroptosis tumor therapy. Chinese J. Polym. Sci. https://doi.org/10.1007/s10118-025-3316-8

Xiao-Mei Zhao, Peng Liu. Synthesis of Amphiphilic pH-Responsive Doxorubicin and Ferrocene-containing Copolyprodrug as Drug Self-delivery System and Its In Vitro Synergistic Apoptosis and Ferroptosis Tumor Therapy[J/OL]. Chinese journal of polymer science, 2025, 431-8.
Zhao, X. M.; Liu, P. Synthesis of amphiphilic pH-responsive doxorubicin and ferrocene-containing copolyprodrug as drug self-delivery system and its in vitro synergistic apoptosis and ferroptosis tumor therapy. Chinese J. Polym. Sci. https://doi.org/10.1007/s10118-025-3316-8 DOI：

Xiao-Mei Zhao, Peng Liu. Synthesis of Amphiphilic pH-Responsive Doxorubicin and Ferrocene-containing Copolyprodrug as Drug Self-delivery System and Its In Vitro Synergistic Apoptosis and Ferroptosis Tumor Therapy[J/OL]. Chinese journal of polymer science, 2025, 431-8. DOI： 10.1007/s10118-025-3316-8.

摘要

Abstract

The diversity

complexity

heterogeneity

and drug resistance of tumors make it challenging to meet the clinical needs of a single apoptosis-inducing chemotherapy. The combination of apoptosis and ferroptosis is expected to address the side effects of chemotherapy and enhance therapeutic efficacy. Here

an amphiphilic pH-responsive doxorubicin (DOX) and ferrocene (Fc)-containing copolyprodrug (P(ADH-DOX-Fc)-PEG) was designed with high DOX and Fc content of 66.5% and 0.58 mmol/g by a facile polycondensation for combining chemotherapy with ferroptosis in cancer treatment. A drug self-delivery system (DSDS) with an average hydrodynamic diameter (

) of 135 nm can be easily obtained

via

self-assembly with the polyprodrug blocks as the hydrophobic core and PEG as the hydrophilic brush. The cumulative DOX release reached 72.7% in the simulated tumor intracellular acidic microenvironment within 56 h

whereas the premature drug leakage was only 6.2% in the simulated normal physiological medium. The 3-(4

5-dimethylthiazol-2-yl)-2

5-diphenyltetrazolium bromide (MTT) assay results indicated an IC

of 8.2 μg/mL

exhibiting enhanced anti-tumor efficacy and a successful combination of apoptosis and ferroptosis

with a combination index (CI) of 0.88.

关键词

Keywords

references

Kaufman n, S. H.; Earnshaw, W. C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 2000 , 256 , 42−49..

Gielecińska, A.; Kciuk, M.; Yahya, E. B.; Ainane, T.; Mujwar, S.; Kontek, R. Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents. BBA-Rev. Cancer 2023 , 1878 , 189024..

Fessart, D.; Robert, J. Mechanisms of cancer drug resistance. Bull. Cancer 2024 , 111 , 37−50..

Liang, P. P.; Ballou, B.; Lv, X. Y.; Si, W. L.; Bruchez, M. P.; Huang, W.; Dong, X. C. Monotherapy and combination therapy using anti-angiogenic nanoagents to fight cancer. Adv. Mater. 2021 , 33 , 2005155..

Jin, W. Q.; Dong, C. Z.; Yang, D. T.; Zhang, R. T.; Jiang, T. S.; Wu, D. C. Nano-carriers of combination tumor physical stimuli-responsive therapies. Curr. Drug Deliv. 2020 , 17 , 577−587..

Yang, M. R.; Zhang, Y.; Hu, Z. M.; Xie, H. N.; Tian, W. L.; Liu, Z. D. Application of hyaluronic acid-based nanoparticles for cancer combination therapy. Int. J. Pharm. 2023 , 646 , 123459..

Dixon, S. J.; Lemberg, K. M.; Lamprecht, M. R.; Skouta, R.; Zaitsev, E. M.; Gleason, C. E.; Patel, D. N.; Bauer, A. J.; Cantley, A. M.; Yang, W. S.; Stockwell, B. 3rd Morrison, B. R. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012 , 149 , 1060−1072..

Tang, D. L.; Chen, X.; Kang, R.; Kroemer, G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021 , 31 , 107−125..

Shen, Z. Y.; Liu, T.; Li, Y.; Lau, J.; Yang, Z.; Fan, W.P.; Zhou, Z. J.; Shi, C. R.; Ke, C. M.; Bregadze, V.; Mandal, S. K.; Liu, Y. J.; Li, Z. H.; Xue, T.; Zhu, G. Z.; Munasinghe, J.; Niu, G.; Wu, A. G.; Chen, X. Y. Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors. ACS Nano 2018 , 12 , 11355−11365..

Lin, J. D.; Yang, H. K.; Zhang, Y. X.; Zou, F.; He, H. C.; Xie, W. J.; Zou, Z. H.; Liu, R.; Xu, Q. F.; Zhang, J.; Zhong, G. W.; Li, Y. J.; Tang, Z. F.; Deng, Y. L.; Cai, S. H.; Wang, L. Y.; Huang, Y. G.; Zhuo, Y. J.; Jiang, X. Q.; Zhong, W. D. Ferrocene-based polymeric nanoparticles carrying doxorubicin for oncotherapeutic combination of chemotherapy and ferroptosis. Small 2023 , 19 , e2205024..

Zhu, L. W.; Du, Y. Z. A promising new approach to cancer therapy: Manipulate ferroptosis by hijacking endogenous iron. Int. J. Pharm. 2024 , 662 , 124517..

Zhou, L. L.; Guan, Q.; Li, W. Y.; Zhang, Z. Y.; Li, Y. A.; Dong, Y.-B. A ferrocene-functionalized covalent organic framework for enhancing chemodynamic therapy via redox dyshomeostasis. Small 2021 , 17 , e2101368..

Wang, H.; Agarwal, P.; Zhao, S. T.; Xu, R. X.; Yu, J. H.; Lu, X. B.; He, X. M. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells. Biomaterials 2015 , 72 , 74−89..

Zhang, J.; Yang, J.; Zuo, T. T.; Ma, S. Y.; Xokrat, N.; Hu, Z. W.; Wang, Z. H.; Xu, R.; Wei, Y. W.; Shen, Q. Heparanase-driven sequential released nanoparticles for ferroptosis and tumor microenvironment modulations synergism in breast cancer therapy. Biomaterials 2021 , 266 , 120429..

Yang, J. H.; Yang, L.; Li, Q.; Zhang, L. K. F errocene-based multifunctional nanoparticles for combined chemo/chemodynamic/photothermal therapy. J. Colloid Interface Sci. 2022 , 626 , 719−728..

Song, C. G.; Yang, F.; Ji, R. X.; Lv, Y.; Wei, Z. Construction of a drug delivery system via pH-responsive polymeric nanomicelles containing ferrocene for DOX release and enhancement of therapeutic effects. ACS Omega 2021 , 6 , 28242−28253..

Ekladious, I.; Colson, Y. L.; Grinstaff, M. W. Polymer-drug conjugate therapeutics: advances, insights and prospects. Nat. Rev. Drug Discov. 2019 , 18 , 273−294..

Liu, P. Polyprodrugs for tumor chemotherapy: from molecular structure to drug release performance. J. Mater. Chem. B 2023 , 11 , 9565−9571..

Lin, C.; Liang, Y. X.; Guo, M. Y.; Saw, P. E.; Xu, X. D. Stimuli-responsive polyprodrug for cancer therapy. Mater. Today Adv. 2022 , 15 , 100266..

Li, J. G.; Li, X. M.; Xie, P.W.; Liu, P. Regulation of drug release performance using mixed doxorubicin-doxorubicin dimer nanoparticles a s a pH-triggered drug self-delivery system. J. Pharm. Anal. 2022 , 12 , 122−128..

Li, J. G.; Li, X. M.; Liu, P. Acid-triggered degradable diblock poly(doxorubicin)-polyethylene glycol polyprodrug with doxorubicin as structural unit for tumor intracellular delivery. Int. J. Pharm. 2021 , 609 , 121142..

Dong, J. L.; Ma, K.; Ding, J. D.; Pei, Y. X.; Pei, Z. C. pH-responsive mannose-modified ferrocene metal-organic frameworks with rare earth for tumor-targeted synchronous chemo/chemodynamic therapy. Bioorg. Med. Chem . 2022 , 69 , 116885..

Mohammadzadeh, A.; Javanbakht, S.; Mohammadi, R.; Kazeminava, F. Ferrocene-functionalized magnetic core-shell nanoparticles based on hydrosilylation reaction for pH-responsive doxorubicin delivery system. Colloid Surf. A-Physicochem. Eng. Aspects 2024 , 703 , 135201..

Suk, J. S.; Xu, Q. G.; Kim, N.; Hanes, J.; Ensign, L. M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 2016 , 99A , 28−51..

Li, X. M.; Zhang, J.; Liu, P. Facile one-pot synthesis of amphiphilic acid/hypoxia co-triggered degradable diblock polyprodrug for tumor selective drug delivery. Int. J. Pharm. 2021 , 606 , 120941..

Xu, X. Y.; Zeng, Z. S.; Chen, J.; Huang, B. Y.; Guan, Z. L.; Huang, Y. J.; Huang, Z. Q.; Zhao, C. S. Tumor-targeted supramolecular catalytic nanoreactor for synergistic chemo/chemodynamic therapy via oxidative stress amplification and cascaded Fenton reaction. Chem. Eng. J. 2020 , 390 , 124628..

Xie, P. W.; Liu, P. Formulation of DOX-dimer with bi-functionalized chitooligosaccharide for tumor-specific self-boosted drug release and synergistic chemo/chemodynamic therapy. Carbohydr. Polym. 2023 , 320 , 121210..

Tan, G.; Hou, G. H.; Qian, J. M.; Wang, Y. P.; Xu, W. J.; Luo, J. J.; Chen, X. B.; Suo, A. L. Hyaluronan-decorated copper-doxorubicin-anlotinib nanoconjugate for targeted synergistic chemo/chemodynamic/antiangiogenic tritherapy against hepatocellular carcinoma. J. Colloid Interface Sci. 2024 , 662 , 857−869..

Kuang, Y. K.; Tian, H. R.; Zhang, M. Z.; He, J. L.; Liu, J.; Ni, P. H. Monoclonal antibody-conjugated polyphosphoester-hyd-DOX prodrug nanoparticles for targeted ch emotherapy of liver cancer cells. Chinese J. Polym. Sci. 2021 , 39 , 1392−1402..

Tewey, K.; Rowe, T.; Yang, L.; Halligan, B.; Liu, L. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 1984 , 226 , 466–468..

Li, X. M.; Zhao, X. M.; Liu, P. Polyprodrug with ultra-high drug content for tumor intracellular acid-triggered degradation and drug delivery. Eur. Polym. J. 2021 , 161 , 110820..

Lei, G.; Zhuang, L.; Gan, B. Y. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interrventions. Cancer Cell 2024 , 42 , 513−534..

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Tumor-Penetrating and Mitochondria-Targeted Drug Delivery Overcomes Doxorubicin Resistance in Lung Cancer

Facile and One-step Direct Synthesis of Poly(valine) as a Robust Drug Nanocarrier for Enhanced Breast Cancer Therapy

Characterization of a Multi-responsive Magnetic Graphene Oxide Nanocomposite Hydrogel and Its Application for DOX Delivery

Related Author

Yi Hu

Meng-Xue Zhou

Jia-Yu Zhang

Xiao-Meng Cai

Rui Dou

Li-Fo Ruan

Wen-Jiang Yang

Wen-Chu Lin

Related Institution

High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China, University of Science and Technology of China

Division of Nuclear Technology and Applications, Institute of High Energy Physics, Chinese Academy of Sciences (CAS)

Key Laboratory of Tea Biology and Resource Utilization of Ministry of Agriculture, Tea Research Institute, Chinese Academy of Agricultural Sciences

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics and University of Chinese Academy of Sciences (UCAS), Chinese Academy of Sciences (CAS)

School of Biomedical Engineering, Sun Yat-sen University

⁰

Synthesis of Amphiphilic pH-Responsive Doxorubicin and Ferrocene-containing Copolyprodrug as Drug Self-delivery System and Its In Vitro Synergistic Apoptosis and Ferroptosis Tumor Therapy

DOI：10.1007/s10118-025-3316-8

摘要

Abstract

关键词

Keywords

references